ACA Tied to Narrowing of Disparities in Access to Care
Nationwide improvements in insurance coverage and access to care seen, even in nonexpansion states
High-Dose Erythropoietin No Benefit for Extreme Preemies
No reduction found in risk for severe neurodevelopmental impairment or death at 2 years of age
Ageism Predicts Significantly Worse Health Outcomes
Older persons who are less educated particularly likely to have adverse health effects of ageism
Single-Payer System Would Likely Save Money
Largest savings predicted to come from simplified billing and lower drug costs
Maternal Distress May Affect Brain Development in Fetuses With CHD
Stress, anxiety, depression more prevalent among women carrying fetuses with congenital heart disease
2011 to 2017 Saw Increase in Spending on DMTs for MS
Increase in annual expenditures on MS DMTs mainly driven by increases in per-prescription costs
Evolution of Approval, Regulation Processes for Drugs Explored
FDA drug review times down from 1983 to 2017, but time from clinical testing to approval did not change
Enterovirus A71 Outbreak in Children ID’d in Colorado Hospital
Neurological findings of myoclonus, ataxia, weakness, and autonomic instability differentiate EV-A71
Doctor Replacement Ratios Higher in Largest, Hospital-Owned Practices
More than double the number of physicians entered than exited large group, hospital-owned practices
2001 to 2016 Saw Drop, Stall in IQ Losses From Chemicals
IQ losses due to in utero PBDE, methylmercury exposure, early life lead exposure decreased or stalled
